DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition

Scientific Reports
Talysa Viera, Praveen L Patidar

Abstract

The overall prognosis for pancreatic cancer remains dismal and potent chemotherapeutic agents that selectively target this cancer are critically needed. Elevated expression of NAD(P)H:quinone oxidoreductase 1 (NQO1) is frequent in pancreatic cancer, and it offers promising tumor-selective targeting. Recently, KP372-1 was identified as a novel NQO1 redox cycling agent that induces cytotoxicity in cancer cells by creating redox imbalance; however, the mechanistic basis of KP372-1-induced cytotoxicity remains elusive. Here, we show that KP372-1 sensitizes NQO1-expressing pancreatic cancer cells and spares immortalized normal pancreatic duct cells, hTERT-HPNE. Notably, we found that KP372-1 is ~ 10- to 20-fold more potent than β-lapachone, another NQO1 substrate, against pancreatic cancer cells. Mechanistically, our data strongly suggest that reactive oxygen species produced by NQO1-dependent redox cycling of KP372-1 cause robust DNA damage, including DNA breaks. Furthermore, we found that KP372-1-induced DNA damage hyperactivates the central DNA damage sensor protein poly(ADP-ribose) polymerase 1 (PARP1) and activates caspase-3 to initiate cell death. Our data also show that the combination of KP372-1 with PARP inhibition creates ...Continue Reading

References

Jan 1, 1990·Methods in Enzymology·C LindL Ernster
Mar 1, 1980·Analytical Biochemistry·C Labarca, K Paigen
Mar 24, 1995·The Journal of Biological Chemistry·T XieA K Jaiswal
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·R Venugopal, A K Jaiswal
Feb 22, 2000·The Journal of Biological Chemistry·J J PinkD A Boothman
Oct 18, 2000·Free Radical Biology & Medicine·A K Jaiswal
May 17, 2003·Cancer Biology & Therapy·Colleen TagliarinoDavid A Boothman
Apr 8, 2004·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Mar 21, 2006·Molecular Cancer Therapeutics·Dimpy KoulW K Alfred Yung
Jul 27, 2006·Journal of Molecular Histology·Melissa S BentleDavid A Boothman
Jul 5, 2007·Proceedings of the National Academy of Sciences of the United States of America·Erik A BeyDavid A Boothman
Sep 6, 2007·Neoplasia : an International Journal for Oncology Research·Eun K ChoiHeon Joo Park
Jan 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Long Shan LiDavid A Boothman
Apr 26, 2011·Methods in Molecular Biology·Johan van MeerlooJacqueline Cloos
Apr 15, 2014·Biochimica Et Biophysica Acta·Elaina N MaginnEuan A Stronach
Nov 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bella KaufmanSusan M Domchek
Jun 24, 2017·Molecular Carcinogenesis·Anne M LewisJoseph J Cullen
Dec 11, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maeve A LoweryEileen M O'Reilly
Jan 9, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edward A MoteaDavid A Boothman
Jun 4, 2019·The New England Journal of Medicine·Talia GolanHedy L Kindler
Aug 30, 2020·Scientific Reports·Praveen L PatidarFarjana J Fattah

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transfections
Assay
Electrophoresis
confocal microscopy

Clinical Trials Mentioned

NCT02514031

Software Mentioned

OpenComet
MIA
CompuSyn
ImageJ
NIH ImageJ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.